临床诊疗
目的 研究在去骨瓣减压术中以神经补片隔离颞肌与硬脑膜对后期颅骨修补术的帮助。方法 回顾分析 23 例去骨瓣大骨瓣减压术后行颅骨修补术的临床资料,随机分为对照组13例,以神经补片隔离颞肌与硬脑膜;观察组10例,不隔离颞肌与硬脑膜。对比颅骨修补术中剥离肌皮瓣时间、术中出血量、术后引流量、术中硬脑膜破损、术后皮下积液、满意度。结果 治疗组的剥离肌皮瓣时间(28.69±9.78)min、术中出血量(36.54±10.59)mL、术后引流量(108.92±29.34)mL几个方面优于对照组,至于术中脑膜破损及术后积液,因例数不够,无统计意义,但由原理及经验判断,治疗组应优于对照组。而治疗组术后外观满意度(77%)高于对照组(40%)。结论 在去骨瓣减压术中以神经补片隔离颞肌与硬脑膜对后期颅骨修补术有明显的帮助。
临床诊疗
目的 观察小剂量阿帕替尼联合经肝动脉化疗栓塞术(TACE)对晚期肝癌的疗效。方法 选择2016年1月1日—2017年12月31日在我院住院治疗的晚期肝癌患者38例,将其随机分为对照组和观察组,每组19例,对照组给予TACE治疗,观察组在TACE治疗的基础上联合口服阿帕替尼(250 mg/d)。随访两组患者的存活状态,Kaplan-Meier 法计算中位生存期,并绘制生存曲线,采用log-rank法比较两组患者生存曲线的差异。结果 对照组和观察组中位生存期分别为4.3月、5.8月,两组生存曲线比较有差异(χ2=4.691,P=0.043)。结论 相比于单纯TACE治疗,小剂量阿帕替尼联合TACE方案可以延长晚期肝癌患者的生存期。
临床诊疗
目的 探究血清外泌体对小鼠烫伤伤口愈合的促进作用及机制。方法 选取我院60只NIH小鼠作为研究对象,对其血清中的外泌体进行提取和分离,建立起皮肤烫伤模型。采用血清外泌体进行治疗,评估治疗的效果,观察皮肤组织的病理变化,检测小鼠成纤维细胞增殖和表皮HaCat细胞迁移使用血清外泌体受到的影响。结果 空白对照组和血清外泌体小鼠烫伤创口愈合时间比较,差异有统计学意义(P<0.05);血清外泌体作用24 h后,不同剂量OD值差异有统计学意义(P<0.05);10 μL Exo组和PBS组内部不同时间点OD值差异均有统计学意义(P<0.05);外泌体组和PBS组24 h的HaCat细胞迁移率相比较,差异有统计学意义(P<0.05)。结论 血清外泌体可以促进小鼠烫伤伤口的愈合,对成纤维细胞的增殖和表皮HaCat细胞的迁移作用也比较显著,可能成为临床治疗烫伤的新手段。
临床诊疗
目的 分析ABCB1基因G2677T、C3435T位点在我国汉族血脂异常人群的分布特征;探讨ABCB1基因G2677T和C3435T多态性与阿托伐他汀降脂疗效之间的关系。方法 依据中国成人血脂异常防治指南判断标准,在中国汉族人群中收集205例受试者,抽取其外周血液样本,利用聚合酶链式反应-限制性片段长度多态分析(PCR-RFLP)技术对受试者ABCB1进行基因分型,同时在阿托伐他汀治疗3个月前后检测总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)、高密度脂蛋白胆固醇(HDL-C)血脂水平,将205例患者治疗后4项指标恢复正常分为A组,治疗后4项指标仍有一项及一项以上异常分为B组,来分析G2677T和C3435T基因多态性与阿托伐他汀降脂疗效的关系,以及G2677T和C3435T等位基因的分布特征。结果 205例患者中G2677T位点GG型、GT型、TT型基因频率分别为19.51%、42.44%、38.05%;C3435T位点CC型、CT型、TT型基因频率分别为34.63%、49.76%、15.61%。G2677T位点A组与B组等位基因突变率为58.46%与60.67%,A组GG型、GT型、TT型基因频率分别为23.08%、36.92%、40.00%,B组GG型、GT型、TT型基因频率分别为13.33%、52.00%、34.67%;C3435T位点A组与B组等位基因突变率为40.77%和40.00%,A组CC型、CT型、TT型基因频率分别为34.62%、 49.23%、16.15%,B组CC型、CT型、TT型基因频率分别为34.67%、50.67%、14.66%;ABCB1 基因G2677T、C3435T位点基因型在A组和B组中分布相同,无差异(P>0.05)。205例患者中,用药前ABCB1基因G2677T位点TT型血浆TC、LDL-C水平高于GT型(P<0.05)。用药后ABCB1基因G2677T位点GT型血浆TC、HDL-C、LDL-C水平低于GG型与TT型(P<0.05);用药后ABCB1基因C3435T位点TT型血浆TC水平低于CC与CT型(P<0.05),而CC型血浆LDL-C水平高于TT型(P<0.05)。结论 ABCB1基因G2677T、C3435T位点多态性与血浆血脂水平有关,但ABCB1基因G2677T、C3435T位点多态性可能与阿托伐他汀3个月降脂疗效无关。
论著
目的 研究牙周牙髓联合治疗对重度牙周炎的手术效果,以及手术预后评价。方法 研究对象选取我院2016年12月—2018年3月间收治的重度牙周炎患者60例(患齿共60颗),将其随机分为观察组(30例)和对照组(30例),分别接受牙周牙髓联合治疗和单纯牙周治疗。比较两组患者的治疗总有效率以及复发率和患者的美观满意度,同时比较治疗前后的各项临床指标水平。结果 观察组患者的治疗总有效率(93.33%)以及复发率(3.33%)均与对照组[(80.00%)、(10.00%)]无差异[(P=0.13,χ2=2.31)、(P=0.30,χ2=1.07)],美观满意度(96.67%)高于对照组(73.33%)(P=0.01,χ2=6.41);治疗一个月后,观察组患者的PD、AL、松动度水平与对照组无差异(P>0.05),龈沟出血指数(SBI)低于对照组(P<0.05);治疗三个月后,观察组的AL、SBI、松动度均低于对照组(P<0.05),PD水平与对照组无差异(P>0.05)。结论 牙周牙髓联合治疗可有效治疗重度牙周炎患者,改善患者临床症状,提高患者美观满意度,值得临床借鉴。
Objective To study the surgical effect of periodontal pulp combined therapy on severe periodontitis and the prognosis of surgery. Methods The study subjects selected 60 patients with severe periodontitis admitted to our hospital from December 2016 to March 2018 (60 teeth), and were randomly divided into observation group (30 cases) and control group (30 cases). The observation group received periodontal treatment with periodontal pulp and the control group received periodontal treatment alone. The total effective rate of treatment and the recurrence rate and the aesthetic satisfaction of the patients were compared between the two groups, and the clinical indicators before and after treatment were compared. Results The total effective rate (93.33%) and recurrence rate (3.33%) of the observation group were not different from the control group [(80.00%), (10.00%)] [(P=0.13, χ2=2.31), (P =0.30, χ2=1.07)], aesthetic satisfaction (96.67%) was higher than the control group (73.33) (P=0.01,χ2=6.41); after one month of treatment, in the PD, AL, looseness of the observation group, there was no difference between the level and the control group (P>0.05), and the sulcus bleeding index (SBI) was lower than that of the control group (P<0.05). After three months of treatment, the AL, SBI and looseness of the observation group were lower than those of the control group (P<0.05). P<0.05), the PD level was not different from the control groups (P>0.05). Conclusion The combined of periodontal and endodontic treatment may be effective to patients with severe periodontitis, improve the clinical symptoms of patients, and increase the aesthetic satisfaction of patients, which is worthy of clinical promotion.
论著
目的 研究输尿管镜下钬激光碎石术治疗输尿管结石疗效及对氧化应激指标的影响。方法 选取我院2016年3月—2017年4月间收治的输尿管结石患者60例,随机将其分为对照组和观察组,每组各30例。观察组接受输尿管钬激光碎石术治疗,对照组接受传统开放手术治疗。比较两组手术前后白细胞介素-10(IL-10)、C反应蛋白(CRP)、白细胞(WBC)等炎性因子以及皮质醇(Cor)、丙二醛(MDA)、超氧化物歧化酶(SOD)等氧化应激指标水平,同时比较两组碎石情况。结果 观察组手术时间、住院天数低于对照组,结石排净率高于对照组(P<0.05);术后,观察组IL-10、CRP、WBC高于对照组(P<0.05);观察组Cor、MDA低于对照组,而SOD高于对照组(P<0.05)。结论 输尿管镜下钬激光碎石术治疗输尿管结石疗效显著,能够抑制炎性因子,减轻应激反应,促进患者疾病康复,值得临床推广。
Objective To study the effect of ureteroscopic holmium laser lithotripsy in the treatment of ureteral calculi and its effect on oxidative stress. Methods Sixty patients with ureteral calculi admitted to our hospital from March 2016 to April 2017 were randomly divided into control group and observation group, with 30 cases in each group. The observation group received ureteroscopic holmium laser lithotripsy and the control group received conventional open surgery. We compared inflammatory factors such as interleukin-10 (IL-10), C-reactive protein (CRP), and white blood cells (WBC) before and after surgery, as well as cortisol (Cor), malondialdehyde (MDA), and superoxide dismutase (SOD) and other levels of oxidative stress indicators, while comparing the two groups of debris. Results The operation time and hospitalization days in the observation group were lower than those in the control group. The stone removal rate was higher than that in the control group (P<0.05). After operation, the IL-10, CRP and WBC in the observation group were higher than those in the control group (P< 0.05). Cor and MDA in the observation group were lower than the control group, and SOD was higher than the control group (P<0.05). Conclusion Ureteroscopic holmium laser lithotripsy is effective in the treatment of ureteral calculi. It can inhibit inflammatory factors, reduce stress response, and promote the recovery of patients' diseases. It is worthy of clinical promotion.
论著
目的 分析献血者献血后血肿(瘀斑)应用不同治疗方法的效果。方法 随机选取147例在广州血液中心献血后出现血肿(瘀斑)的献血者,根据其采用处理方式的差异分为甲组(n=66)、乙组(n=48)、丙组(n=33),为甲组献血者实施冷热敷法,为乙组献血者实施马铃薯片贴敷法,为丙组献血者实施喜辽妥(多磺酸粘多糖)软膏外敷法。结果 乙组献血者临床总有效率高于甲组献血者,差异有统计学意义(χ2=4.63,P<0.05),丙组献血者临床总有效率高于甲组献血者,差异有统计学意义(χ2=13.99,P<0.05),丙组献血者临床总有效率高于乙组献血者,2组差异有统计学意义(χ2=3.99,P<0.05)。结论 献血者献血后血肿应用喜疗妥软膏外敷法疗效确切,可使其身心健康得到改善。
Objective To analyze the effects of different treatment methods on blood donors with haematoma(or bruise) after blood donation. Methods 147 blood donors with haematoma(or bruise) after blood donation in our blood station were randomly selected. According to the difference of treatment methods, they were divided into group A (n=66), group B (n=48) and group C (n=33), for the group A of blood donors to carry out cold and hot compress method, for the group B blood donors to implement the potato slice application method, for the group C blood donors to implement the hi-treatment ointment external application method. Results The total effective rate of group B blood donors was higher than that of group A blood donors. The difference was statistically significant (χ2=4.63,P<0.05). The total clinical effective rate of group C blood donors was higher than that of group A blood donors. There is statistical significance (χ2=13.99,P<0.05). The total effective rate of donors in group C was higher than that in group B. The difference between the two groups was statistically significant (χ2=3.99,P<0.05). Conclusion The effect of external application of Hirudoid(Mucopolysaccharide Polysulfate Cream) on blood donors after blood donation is effective, which may improve their physical and mental health.
论著
目的 探讨功能区矢状窦镰旁脑膜瘤患者采用显微镜手术对其手术情况及症状改善的影响。方法 选2015年5月—2018年5月我院择期行手术治疗的40例功能区矢状窦镰旁脑膜瘤患者,参照随机数表法分为对照组(n=20)和研究组(n=20)。对照组采用常规手术治疗,研究组采用显微镜手术,对比两组手术情况及术后症状情况。结果 研究组术中输血量及肿瘤全切除率比对照组均低,住院时间和手术时间均较短,差异有统计学意义(P<0.05);相较于对照组,研究组术后症状改善发生率较高(95.00% vs 60.00%),症状加重发生率较低(0.00% vs 35.00%),差异有统计学意义(P<0.05)。结论 显微镜手术可有效减少功能区矢状窦镰旁脑膜瘤患者术中输血量,缩短手术时间,改善临床症状,促进患者术后恢复。
Objective To investigate the effect of microsurgery on the operation and symptom improvement of patients with para-sagittal sinus meningioma in functional area. Methods From May 2015 to May 2018, 40 patients with parasickle meningioma of sagittal sinus in our hospital were randomly divided into two groups: control group (n = 20) and study group (n = 20). The patients in the control group were treated with conventional operation, and the patients in the study group were treated with microscope. Results The volume of blood transfusion and the total resection rate of tumor in the study group were lower than those in the control group, and the duration of hospitalization and operation were shorter than those in the control group. Compared with the control group, the incidence of symptom improvement in the study group was higher (95.00% vs 60.00%), the incidence of symptom exacerbation was lower (0.00% vs 35.00%), the difference was statistically significant (P< 0. 05). Conclusion Microscopy may effectively reduce the amount of blood transfusion, shorten the operation time, improve clinical symptoms and promote postoperative recovery in patients with parasagittal sinus meningioma.
论著
目的 初步探讨D-二聚体对判断女性恶性肿瘤病情和疗效观察的应用价值与诊断效能。方法 选取2016年3月—2017年12月间在佛山第一人民医院乳腺肿瘤内科住院治疗的女性恶性肿瘤患者149例,早期术后患者(术后组)58例,晚期复发转移患者(晚期组)91例,测定其接受化疗前后的血浆D-二聚体水平(分别记作D1、D2),分析D-二聚体浓度变化(ΔD=D2-D1)与疗效的相关性。D-二聚体浓度(ng/mL)用中位数(四分位间距)表示,治疗前后配对样本比较用Wilcoxon秩和检验,两组间独立+样本比较用Mann-Whitney U检验,以Spearman法分析两组资料的相关性是否有统计学意义。结果 术后组患者化疗后D-二聚体水平低于化疗前(ΔD=-184.8,P<0.0001),D1、D2均与年龄正相关(P<0.01),r2分别为0.356,0.389。晚期组患者中,化疗后有33例出现病情进展(progressive disease, PD组),58例获得疾病缓解或稳定(非PD组)。PD组化疗前基线水平高于非PD组(1 586 vs 754.2,P<0.01),接受化疗后PD组D-二聚体较基线水平升高(ΔD=1 124,P<0.0001),非PD组较基线水平下降(ΔD=-153.3,P=0.004 5),PD组化疗后D-二聚体水平高于非PD组(2 511 vs 525.8,P<0.01)。以ΔD、D1、D2诊断是否PD分别进行受试者工作特征曲线(receiver operating characteristic curve,ROC)分析,结果显示ROC曲线下面积分别为0.8 603(95% CI:0.768 5~0.952 0)、0.674 0(95% CI:0.558 2~0.759 7)、0.895 6(95%CI:0.829 1~0.962 1),对诊断PD有一定准确性。当ΔD<-145.4 ng/mL、D1>1 375 ng/mL、D2>1 033 ng/mL时,Youden指数最大,诊断PD的准确性较高。结论 血浆D-二聚体的变化与肿瘤负荷密切相关,有助于女性恶性肿瘤病情的判断和疗效观察及评价预后,对辅助判断病情进展上的具有较高的诊断效能。
Objective To investigate the clinical significance and diagnostic value of plasma D-dimer measurement in response evaluation of female patients with tumor. Methods 149 female cancer patients were enrolled, in which there were 58 post-operative early staged cases(post-operative group), 91 metastatic cases(metastatic group). D-dimer levels before chemotherapy (D1) and after the last cycle of chemotherapy (D2) were assessed and analyzed to examine whether they are correlated to response of therapy. D-dimer levels were presented as median(25th percentile,75th percentile) and compared using Wilcoxon signed-rank test(for paired samples) and Mann-Whitney U test(for independent samples). Spearman rank tests were conducted to show the correlation of two variables. Results In post-operative group,D2 was lower than D1(ΔD=-184.8,P<0.0001),and both of D1 and D2 were positively correlated with age(r2= 0.356,0.389,respectively,P<0.01). In metastatic group, after chemotherapy,33 cases had progressive diseases(PD group), while 58 cases gained response or stable diseases(non-PD group). Baseline D-dimer level of PD group was higher than that of non-PD group(1586 vs 754.2,P<0.01),and after chemotherapy the case was similar(2511 vs 525.8,P<0.01). After chemotherapy, D-dimer level increased in PD group(ΔD=1124,P<0.0001), and decreased in non-PD group(ΔD=-153.3,P=0.0045).We compared the abilities of the ΔD(ΔD=D2-D1), D1and D2 to discriminate between responders and non-responders using receiver operating characteristic curves(ROC). The areas under the curve (AUC) of the ΔD, D1and D2, were 0.8603(95%CI:0.7685-0.9520)、0.6740(95%CI:0.5582-0.7597)、0.8956(95%CI:0.8291-0.9621), respectively. The appropriate cut-off values with biggest Youden index of D-dimer for non-responders were as follows: ΔD<-145.4 ng/mL,D1>1375ng/mL,D2>1033ng/mL. Conclusion Plasma D-dimer level is strongly associated with tumor burden. D-dimer could be used to predict prognosis and treatment response in female patients with tumor.
论著
目的 通过比较炎症性肠病(IBD)患者的血脂水平,探讨炎症性肠病疾病活动程度与血脂的相关性。方法 收集2013年1月—2018年5月在南方医科大学附属南海医院住院的159例IBD患者和159例健康对照为研究对象,检测分析两组的血浆TG、TC、LDL-C、HDL-C、脂蛋白a、白蛋白和超敏C反应蛋白(hCRP)水平差异,分析IBD患者疾病活动程度与血脂异常的关系。结果 与对照组比较,IBD患者的TG、TC、LDL-C、HDL-C和白蛋白均下降,但脂蛋白a升高(P<0.05),且CD组的TC、LDL-C、HDL-C、白蛋白均较UC组更低(P<0.05)。TC、LDL-C、HDL-C等胆固醇水平随IBD疾病活动程度加重而逐渐下降,且与hCPR呈负相关,脂蛋白a与hCRP呈正相关性,但未见TG水平与疾病活动相关。结论 IBD患者的胆固醇水平下降,脂蛋白a升高,CD患者更明显,胆固醇水平随IBD病情加重逐渐下降,且与hCRP呈负相关。
Objective To explore the correlations between disease activity of inflammatory bowel disease(IBD) and lipid profiles levels by compare the levels of plasma lipids in patients with IBD. Methods A total of 159 IBD patients admitted to Nanhai Hospital of Southern Medical University from January 2013 to May 2018 were included in the study and the clinical data were collected. There were 159 healthy people recruited in the control group. The differences of plasma levels of triglycerides(TG), total cholesterol(TC), low-density lipoprotein cholesterol(LDL-C), high-density lipoprotein cholesterol(HDL-C), lipoprotein(a), albumin and high-sensitivity C-reactive protein(hCRP) between these two groups were analyzed respectively. The relationships between lipids levels and the severity of IBD were analyzed. Results Plasma levels of TG,TC,LDL-C,HDL-C and albumin were lower in IBD group than those in control group,but lipoprotein(a) was higher than control group(P<0.05). The levels of TC,LDL-C,HDL-C and albumin were lower in CD patients compared to those of UC(P<0.05). Plasma levels of TC,LDL-C,HDL-C gradually decreased with the severity of IBD. TC,LDL-C,HDL-C values were negatively correlated with hCRP levels in IBD patients. And lipoprotein(a) values was positively correlated with hCRP levels in IBD patient. However, there was no association between TG levels and the severity of IBD. Conclusion TG、TC、LDL-C、HDL-C levels are decreased and lipoprotein(a) is increased in IBD patients, especially CD patients, compared with healthy controls. Moreover, the cholesterol levels are negatively associated with more severe disease activity.